Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis

Abstract Background Serum chitotriosidase is a promising biomarker that has shown high specificity and sensitivity in patients with sarcoidosis. The aim of this study was to investigate correlations between serum chitotriosidase, clinical phenotypes, disease localizations and different radiological...

Full description

Bibliographic Details
Main Authors:	David Bennett, Paolo Cameli, Nicola Lanzarone, Loredana Carobene, Nicola Bianchi, Annalisa Fui, Luigi Rizzi, Laura Bergantini, Giuseppe Cillis, Miriana d’Alessandro, Maria Antonietta Mazzei, Rosa Metella Refini, Piersante Sestini, Elena Bargagli, Paola Rottoli
Format:	Article
Language:	English
Published:	BMC 2020-01-01
Series:	Respiratory Research
Subjects:	Chitotriosidase Sarcoidosis Biomarkers Clinical evaluation
Online Access:	https://doi.org/10.1186/s12931-019-1263-z

Similar Items

Correction to: Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis
by: David Bennett, et al.
Published: (2020-01-01)

The Use of Chitotriosidase as a Marker of Active Sarcoidosis and in the Diagnosis of Fever of Unknown Origin (FUO)
by: Angela Maria Di Francesco, et al.
Published: (2021-11-01)

Verifying sarcoidosis activity: Chitotriosidase versus ACE in sarcoidosis: A case-control study
by: Popević Spasoje, et al.
Published: (2016-01-01)

Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility
by: Paolo Cameli, et al.
Published: (2020-10-01)

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy
by: Orchard Paul J, et al.
Published: (2011-10-01)

Human chitotriosidase helps Plasmodium falciparum in the Anopheles midgut
by: M. Di Luca, R. Romi, F. Severini, L . Toma, M. Musumeci, A.M. Fausto, M. Mazzini,G. Gambellini & S. Musumeci
Published: (2006-09-01)

Strain Echocardiography Is a Promising Tool for the Prognostic Assessment of Sarcoidosis
by: Paolo Cameli, et al.
Published: (2021-10-01)

Expression of Chitotriosidase in Macrophages Modulates Atherosclerotic Plaque Formation in Hyperlipidemic Mice
by: Jonathan Yap, et al.
Published: (2020-06-01)

The relation between delivery type and cord blood levels of chitotriosidase and Troponin T
by: Tunc Turan, et al.
Published: (2010-12-01)

Chitotriosidase and Neopterin as Potential Biomarkers for the Evaluation of Complicated Cholecystitis—A Pilot Study
by: Vlad-Ionuţ Nechita, et al.
Published: (2023-02-01)

Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
by: Maren Freigang, et al.
Published: (2021-07-01)

Serum Concentrations of KL-6 in Patients with IPF and Lung Cancer and Serial Measurements of KL-6 in IPF Patients Treated with Antifibrotic Therapy
by: Miriana d’Alessandro, et al.
Published: (2021-02-01)

Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study
by: Paolo Cameli, et al.
Published: (2020-09-01)

Exploratory Evaluation of Neopterin and Chitotriosidase as Potential Circulating Biomarkers for Colorectal Cancer
by: Andra Ciocan, et al.
Published: (2023-03-01)

Chitotriosidase as a biomarker for gangliosidoses
by: Sarah Kim, et al.
Published: (2021-12-01)

Chitotriosidase-1 levels in Iraqi Type 2 Diabetic Patients with Thyroid Disorders
by: Mohammed Alwan Iedan, et al.
Published: (2019-05-01)

Evaluation of Chitotriosidase and Neopterin as Biomarkers of Microvascular Complications in Patients with Type 1 Diabetes Mellitus
by: Ancuța Cutaș, et al.
Published: (2021-02-01)

The survival prediction of hospitalized patients with COVID-19: the role of chitotriosidase level in peripheral blood
by: Ekaterina S. Schelkanovtseva, et al.
Published: (2023-09-01)

PD1, CTLA4 and TIGIT Expression on T and NK Cells in Granulomatous Diseases: Sarcoidosis and ANCA-Associated Vasculitis
by: Miriana d’Alessandro, et al.
Published: (2022-12-01)

Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review
by: Paolo Cameli, et al.
Published: (2020-08-01)

Increased chitotriosidase activities in patients with rheumatoid arthritis: A possible novel marker?
by: Basok Banu Isbilen, et al.
Published: (2014-01-01)

Chitotriosidase and Neopterin as Two Novel Potential Biomarkers for Advanced Stage and Survival Prediction in Gastric Cancer—A Pilot Study
by: Vlad-Ionuţ Nechita, et al.
Published: (2023-04-01)

Immunological Pathways in Sarcoidosis and Autoimmune Rheumatic Disorders—Similarities and Differences in an Italian Prospective Real-Life Preliminary Study
by: Miriana d’Alessandro, et al.
Published: (2023-05-01)

Chitotriosidase, a biomarker of amyotrophic lateral sclerosis, accentuates neurodegeneration in spinal motor neurons through neuroinflammation
by: Anu Mary Varghese, et al.
Published: (2020-08-01)

The Genetic Polymorphisms of 24 Base Pair Duplication and Point G102S of Human Chitotriosidase to Bancroftian Filariasis at the Thai–Myanmar Border
by: Vivornpun Sanprasert, et al.
Published: (2019-03-01)

Combined Sarcoidosis and Idiopathic Pulmonary Fibrosis (CSIPF): A New Phenotype or a Fortuitous Overlap? Scoping Review and Case Series
by: Laura Bergantini, et al.
Published: (2022-04-01)

Altered Serum Chitotriosidase Activity and Irisin Level in Obese Children
by: Ferit Durankuş, et al.
Published: (2021-09-01)

The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study
by: Paolo Cameli, et al.
Published: (2022-08-01)

Systematic Review and Metanalysis of Oncomarkers in IPF Patients and Serial Changes of Oncomarkers in a Prospective Italian Real-Life Case Series
by: Miriana d’Alessandro, et al.
Published: (2021-01-01)

A 20-Year Longitudinal Study of Plasma Chitotriosidase Activity in Treated Gaucher Disease Type 1 and 3 Patients—A Qualitative and Quantitative Approach
by: Paulina Szymańska-Rożek, et al.
Published: (2023-02-01)

Characterization of natural killer and T cells in bronchoalveolar lavage and peripheral blood of sarcoidosis patients
by: Laura Bergantini, et al.
Published: (2023-01-01)

Overexpression of chitotriosidase and YKL-40 in peripheral blood and sputum of healthy smokers and patients with chronic obstructive pulmonary disease
by: Majewski S, et al.
Published: (2019-07-01)

An uncommon cause of early infantile liver disease and raised chitotriosidase
by: Srividya Sreekantam, et al.
Published: (2020-07-01)

CD103 Expression on Regulatory and Follicular T Cells in Lymph Nodes, Bronchoalveolar Lavage Fluid and Peripheral Blood of Sarcoidosis Patients
by: Miriana d’Alessandro, et al.
Published: (2022-05-01)

Editorial: Sarcoidosis and autoimmunity: From bench to bedside
by: Miriana d'Alessandro
Published: (2023-02-01)

Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications
by: Luca D’Onofrio, et al.
Published: (2023-10-01)

Imbalance of Lymphocyte Subsets and CD45RA-Expressing Cells in Intrathoracic Lymph Nodes, Alveolar Compartment and Bloodstream of Pulmonary Sarcoidosis Patients
by: Miriana d’Alessandro, et al.
Published: (2023-06-01)

Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression
by: Yago Côrtes Pinheiro Gomes, et al.
Published: (2022-08-01)

Longitudinal and Comparative Measures of Serum Chitotriosidase and YKL-40 in Patients With Idiopathic Pulmonary Fibrosis
by: Sebastian Majewski, et al.
Published: (2022-02-01)

Inhibition of Macrophage-Specific CHIT1 as an Approach to Treat Airway Remodeling in Severe Asthma
by: Piotr Sklepkiewicz, et al.
Published: (2023-03-01)